Advances paid per center

No definition available.

Name:	grfs_AdvancesPaidPerCenter
Namespace Prefix:	grfs_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Management fee

+ References

No definition available.

+ Details

Name:	grfs_ManagementFee
Namespace Prefix:	grfs_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Represents the phases of centers on numbers.

+ References

No definition available.

+ Details

Name:	grfs_NumberOfPhasesInWhichCentersHasBeenAcquired
Namespace Prefix:	grfs_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of plasma center lease agreements for which entity acts as guarantor

+ References

No definition available.

+ Details

Name:	grfs_NumberOfPlasmaCenterLeaseAgreementsForWhichEntityActsAsGuarantor
Namespace Prefix:	grfs_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of plasma centers acquired

+ References

No definition available.

+ Details

Name:	grfs_NumberOfPlasmaCentersAcquired
Namespace Prefix:	grfs_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of plasma centers acquired per group of centers.

+ References

No definition available.

+ Details

Name:	grfs_NumberOfPlasmaCentersAcquiredPerGroupOfCenters
Namespace Prefix:	grfs_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the plasma centers on numbers.

+ References

No definition available.

+ Details

Name:	grfs_NumberOfPlasmaCentersToBeOpened
Namespace Prefix:	grfs_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Period after opening of each respective center that entity has committed to purchase the center.

+ References

No definition available.

+ Details

Name:	grfs_PeriodAfterOpeningOfEachRespectiveCenterThatEntityHasCommittedToPurchasingCenter
Namespace Prefix:	grfs_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Plasma center leasing agreements, amounts guaranteed by entity

+ References

No definition available.

+ Details

Name:	grfs_PlasmaCenterLeasingAgreementsAmountsGuaranteedByEntity
Namespace Prefix:	grfs_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The cash outflow for the purchase of plasma.

+ References

No definition available.

+ Details

Name:	grfs_PurchaseOfPlasma
Namespace Prefix:	grfs_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Total advances paid for centers

+ References

No definition available.

+ Details

Name:	grfs_TotalAdvancesPaidForCenters
Namespace Prefix:	grfs_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Total for all business combinations [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 3
-IssueDate 2025-01-01
-Paragraph B64
-Subparagraph f
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64_f&doctype=Appendix&subtype=B
-URIDate 2025-03-27

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Note Effective 2027-01-01
-Name IFRS
-Number 19
-IssueDate 2025-01-01
-Paragraph 35
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_35_e&doctype=Standard
-URIDate 2025-03-27

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Note Effective 2027-01-01
-Name IFRS
-Number 19
-IssueDate 2025-01-01
-Paragraph 35
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_35_e&doctype=Standard
-URIDate 2025-03-27

+ Details

Name:	ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The fair value, at acquisition date, of cash transferred as consideration in a business combination. [Refer: Total for all business combinations [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 3
-IssueDate 2025-01-01
-Paragraph B64
-Subparagraph f
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64_f_i&doctype=Appendix&subtype=B
-URIDate 2025-03-27

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Note Effective 2027-01-01
-Name IFRS
-Number 19
-IssueDate 2025-01-01
-Paragraph 35
-Subparagraph e
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_35_e_i&doctype=Standard
-URIDate 2025-03-27

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Note Effective 2027-01-01
-Name IFRS
-Number 19
-IssueDate 2025-01-01
-Paragraph 35
-Subparagraph e
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_35_e_i&doctype=Standard
-URIDate 2025-03-27

+ Details

Name:	ifrs-full_CashTransferred
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.

+ References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The proportion of ownership interest in a joint operation attributable to the entity. [Refer: Total for all joint operations [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2025-01-01
-Paragraph 21
-Subparagraph a
-Clause iv
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_21_a_iv&doctype=Standard
-URIDate 2025-03-27

+ Details

Name:	ifrs-full_ProportionOfOwnershipInterestInJointOperation
Namespace Prefix:	ifrs-full_
Data Type:	dtr-2022:percentItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	ifrs-full_BusinessCombinationsAxis=grfs_PlasmaCentersAcquiredFromImmunotekMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_BusinessCombinationsAxis=grfs_Group1CentersAndGroup2CentersMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_BusinessCombinationsAxis=grfs_Group3CentersAndGroup4CentersMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_BusinessCombinationsAxis=grfs_Group3CentersMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_BusinessCombinationsAxis=grfs_Group4CentersMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_JointOperationsAxis=grfs_BiotekAmericaLlcMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_CounterpartiesAxis=grfs_ImmunotekBioCentersLlcMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_CounterpartiesAxis=grfs_BiotekAmericaLlcMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=grfs_ImmunotekGhLlcMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Equity-Accounted Investees and Joint Business - Joint Arrangement (Details) € in Millions, $ in Millions				1 Months Ended					4 Months Ended	12 Months Ended			30 Months Ended
	Feb. 03, 2025 USD ($)	Jan. 02, 2025 USD ($)	Jul. 31, 2021	Feb. 28, 2025 Center	Jan. 31, 2025 Center	Jul. 31, 2024 USD ($) Center	Apr. 30, 2024 Center	Jul. 31, 2021	Jul. 31, 2024 USD ($) Center	Dec. 31, 2025 USD ($) Center	Dec. 31, 2024 EUR (€)	Dec. 31, 2023 EUR (€)	Dec. 31, 2023 EUR (€)	Feb. 03, 2025 EUR (€)	Jan. 02, 2025 EUR (€)	Jul. 31, 2024 EUR (€)	Jul. 31, 2021 USD ($)	Jul. 31, 2021 EUR (€)	Jul. 31, 2021 Center
Plasma centers acquired from Immunotek
Equity-Accounted Investees and Joint Business
Number of plasma centers to be opened																			28
Total business combination cost						$ 547			$ 547							€ 514
Number of plasma centers acquired				6	8				14
Number of plasma centers acquired per group of centers						7	7
Number of phases the centers has acquired						2	2
Plasma center leasing agreements, amounts guaranteed by entity \| $	$ 20
Group 1 centers and Group 2 centers
Equity-Accounted Investees and Joint Business
Total business combination cost						$ 266			$ 266							€ 246
Number of plasma centers acquired									14
Group 3 centers and Group 4 centers
Equity-Accounted Investees and Joint Business
Total business combination cost	281									$ 140	€ 134			€ 268
Number of plasma centers acquired										14
Number of plasma center lease agreements for which entity acts as guarantor										2
Group 3 centers
Equity-Accounted Investees and Joint Business
Cash transferred										$ 78	75
Total business combination cost		$ 79													€ 75
Number of plasma centers acquired		8
Group 4 centers
Equity-Accounted Investees and Joint Business
Cash transferred										$ 62	59
Total business combination cost	$ 62													€ 59
Number of plasma centers acquired	6									6
Biotek America LLC
Equity-Accounted Investees and Joint Business
Number of plasma centers to be opened			28					28											28
Period after opening of each respective center that entity has committed to purchasing the center			3 years
Proportion of ownership interest in joint arrangement			75.00%					75.00%
ImmunoTek Bio Centers, LLC
Equity-Accounted Investees and Joint Business
Number of plasma centers to be opened																			28
Number of plasma centers acquired										14
Advances paid per center \| $																	$ 5
Total advances paid for centers																	$ 140	€ 134
Management fee \| €											28	€ 15	€ 8
Biotek America LLC
Equity-Accounted Investees and Joint Business
Purchase of plasma \| €											€ 236	€ 234
ImmunoTek GH LLC \| Biotek America LLC
Equity-Accounted Investees and Joint Business
Proportion of ownership interest in joint arrangement			25.00%					25.00%